Safety evaluation of second year treatment of age-related macular degeneration with pegaptanib sodium (Macugen): VEGF inhibition study in ocular neovascularization (VISION)

被引：0

|

作者：

Mieler, W

机构：

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2005年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

1380

引用

收藏

页数：1

相关论文

共 50 条

[31] Treatment of age-related macular degeneration: Beyond VEGF
Joan W. Miller
Japanese Journal of Ophthalmology, 2010, 54 : 523 - 528
[32] Treatment of Age-Related Macular Degeneration: Beyond VEGF
Miller, Joan W.
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2010, 54 (06) : 523 - 528
[33] Pegaptanib: choroidal neovascularization in patients with age-related macular degeneration and previous arterial thromboembolic events
Parodi, Maurizio Battaglia
Di Bartolo, Emanuele
Brue, Claudia
Cappello, Ezio
Furino, Claudio
Giuffrida, Sebastiano
Imparato, Manuela
Reibaldi, Michele
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2018, 28 (01) : 58 - 62
[34] Combined Pegaptanib sodium (Macugen) and photodynamic therapy in predominantly classic juxtafoveal choroidal neovascularisation in age related macular degeneration
Calvo-Gonzalez, C.
Reche-Frutos, J.
Donate-Lopez, J.
Garcia-Feijoo, J.
Leila, M.
Fernandez-Perez, C.
Garcia-Sanchez, J.
BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (01) : 74 - 75
[35] A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitus
Theresa Dombi
Kenneth K Kwok
Marla B Sultan
BMC Ophthalmology, 12
[36] Safety and efficacy of intravitreal bevacizumab followed by pegaptanib maintenance as a treatment regimen for age-related macular degeneration
Hughes, Mark S.
Sang, Delia N.
OPHTHALMIC SURGERY LASERS & IMAGING, 2006, 37 (06) : 446 - 454
[37] Cost-effective analysis of pegaptanib (Macugen®) as compared with ranibizumab (Lucentis®) for treating in age-related macular degeneration (AMD)
Lu, L. Y.
McGhan, W.
VALUE IN HEALTH, 2008, 11 (03) : A288 - A288
[38] A pharmacoeconomic evaluation of pegaptanib for the management of age-related macular degeneration (AMD) in Mexico
Vega-Hernandez, G. Y.
Idrovo-Velandia, J.
Rivas, R.
Zapata, L.
Venegas, J.
Ramirez, H.
Mould-Quevedo, J.
Davila-Loaiza, G.
VALUE IN HEALTH, 2008, 11 (03) : A290 - A290
[39] Current treatment of choroidal neovascularization in age-related macular degeneration
Donati, G
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2002, 25 (07): : 740 - 746
[40] Age-related macular degeneration: Evaluation and treatment
Moshfeghi, DM
Lewis, H
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2003, 70 (12) : 1017 - +

← 1 2 3 4 5 →